Schedule a meeting with us
We are looking forward to connecting with you in Chicago! Visit us at Booth 25081 to explore the clinical impact of our expanding portfolio, including innovations in hereditary cancer testing, somatic tumor profiling, and molecular residual disease (MRD) detection.
2026 ASCO® Annual Meeting
Location: McCormick Place, Chicago, IL
When: May 29 – June 2, 2026
Booth: #25081
Topic: Ultra-Sensitive Molecular Residual Disease Detection with Myriad’s Precise MRD™ Test
Date and Time: Sunday, May 31, 2026 | 9:30 to 10:30 AM CT
Speaker: Dale Muzzey, PhD, Chief Scientific Officer, Myriad Genetics®
*Not an official event of the 2026 ASCO® Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, or Conquer Cancer®, the ASCO Foundation. Not CME-accredited.
Request more information about how Myriad’s Oncology solutions can benefit you/your patients.
By submitting your personal information, you agree to be contacted with newsletters, marketing or promotional materials, and other information that may be of interest to you. You may opt-out of receiving communications from us by following the unsubscribe link or the instructions provided in the communication we send. For further information on our privacy practices and commitment to protecting your privacy, please visit our Privacy Notice.
Contact Information
©Myriad Genetics, MyRisk, Precise Tumor, MyChoice, Prolaris, BRACAnalysis CDx, RiskScore, and their respective logos, are either trademarks or registered trademarks of Myriad Genetics, Inc. and its subsidiaries in the United States and other jurisdictions.